We’re proud to support the ongoing dialogue around investment in anti-infectives at the World AMR Congress. On September 6th, Aleks Engel will be moderating a panel focused on addressing market challenges and strengthening the antibiotic pipeline to combat AMR. We are looking forward to hearing an inspiring group of leaders discuss advancing strategies for innovation in the fight against antimicrobial resistance. Register here: https://bit.ly/474wy2V #AMR #WorldAMRCongress
This September 6, catch the #WorldAMRCongress' esteemed panel hitting the Innovation Showcase stage: "𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀 𝗣𝗮𝗻𝗲𝗹: 𝗦𝗲𝗲𝗸𝗶𝗻𝗴 𝗥𝗲𝘁𝘂𝗿𝗻𝘀 𝗳𝗿𝗼𝗺 𝗜𝗻𝘃𝗲𝘀𝘁𝗶𝗻𝗴 𝗶𝗻 𝗔𝗻𝘁𝗶-𝗜𝗻𝗳𝗲𝗰𝘁𝗶𝘃𝗲𝘀", with... 𝙈𝙤𝙙𝙚𝙧𝙖𝙩𝙤𝙧 ⬇️ ▶ Aleks Engel, Director, REPAIR IMPACT FUND, Novo Holdings 𝙋𝙖𝙣𝙚𝙡𝙞𝙨𝙩𝙨 ⬇️ ▶ Fei Shen, Managing Director, Boehringer Ingelheim Venture Fund USA ▶ Martin Heidecker, Chief Investment Officer, AMR Action Fund ▶ Bita Sehat, PhD, MBA, Senior Investment Director, Trill Impact Ventures ▶ Mark Bamforth, Member of the General Partners, Kineticos AMR Accelerator Fund I, Kineticos Life Sciences Don't miss out on the insights and strategies from these key players shaping the future of anti-infective investment! 🗣️ 𝗚𝗲𝘁 𝘆𝗼𝘂𝗿 𝟲𝟬% 𝗼𝗳𝗳 𝘁𝗶𝗰𝗸𝗲𝘁 𝘁𝗼𝗱𝗮𝘆: https://lnkd.in/eWcqExVC